Biomarker Panels for Discriminating Risk of CKD Progression in Children

被引:0
作者
Greenberg, Jason H. [1 ,2 ]
Abraham, Alison G. [3 ]
Xu, Yunwen [4 ]
Schelling, Jeffrey R. [5 ]
Coca, Steven G. [6 ]
Schrauben, Sarah J. [7 ,8 ]
Wilson, F. Perry [2 ]
Waikar, Sushrut S. [9 ,10 ]
Vasan, Ramachandran S. [11 ,12 ]
Gutierrez, Orlando M. [13 ]
Shlipak, Michael G. [14 ]
Ix, Joachim H. [15 ]
Warady, Bradley A. [16 ]
Kimmel, Paul L. [17 ]
Bonventre, Joseph V. [18 ]
Parikh, Chirag R. [19 ]
Denburg, Michelle [20 ]
Furth, Susan [1 ,20 ]
CKD Biomarkers Consortium
机构
[1] Yale Univ, Sch Med, Dept Pediat, Sect Nephrol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Clin & Translat Res Accelerator, New Haven, CT 06520 USA
[3] Univ Colorado, Dept Epidemiol, Denver, CO USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, NY USA
[5] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys & Med, Div Nephrol, Cleveland, OH USA
[6] Icahn Sch Med Mt Sinai, Dept Internal Med, Sect Nephrol, New York, NY USA
[7] Univ Penn, Clin Ctr Biostat & Epidemiol, Perelman Sch Med, Dept Med, Philadelphia, PA USA
[8] Univ Penn, Clin Ctr Biostat & Epidemiol, Perelman Sch Med, Dept Epidemiol, Philadelphia, PA USA
[9] Boston Univ, Sch Med, Sect Nephrol, Boston, MA 02118 USA
[10] Boston Med Ctr, Boston, MA USA
[11] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[12] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA USA
[13] Univ Alabama Birmingham, Dept Med, Sect Nephrol, Birmingham, AL USA
[14] Univ Calif San Francisco, San Francisco Vet Affairs Healthcare Syst, Dept Med, Kidney Hlth Res Collaborat, San Francisco, CA USA
[15] Univ Calif San Diego, San Francisco Vet Affairs Healthcare Syst, Dept Med, Div Nephrol Hypertens,Nephrol Sect, San Diego, CA 92161 USA
[16] Childrens Mercy Kansas City, Dept Pediat, Div Nephrol, Kansas City, MO USA
[17] NIH, Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD USA
[18] Brigham & Womens Hosp, Dept Internal Med, Sect Nephrol, Boston, MA USA
[19] Johns Hopkins Sch Med, Dept Internal Med, Sect Nephrol, Baltimore, NY USA
[20] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat,Div Nephrol, Philadelphia, PA USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2025年
关键词
children; chronic GN; CKD; pediatric nephrology; progression of renal failure; proteinuria; risk factors; CHRONIC KIDNEY-DISEASE; SURVIVAL;
D O I
10.1681/ASN.0000000602
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Key PointsPlasma biomarkers (kidney injury molecule-1, KIM-1), urine biomarkers (EGF/creatinine and urine albumin-creatinine ratio), and eGFR identified four prognostic groups in children with CKD progression.A panel of biomarkers may better capture the complexity of kidney disease in children and may allow for a broader assessment of kidney health.BackgroundWe have previously studied biomarkers of tubular health (EGF), injury (kidney injury molecule-1 [KIM-1]), dysfunction (alpha-1 microglobulin), and inflammation (TNF receptor-1, TNF receptor-2, monocyte chemoattractant protein-1, YKL-40, and soluble urokinase plasminogen activator receptor) and demonstrated that plasma KIM-1, TNF receptor-1, TNF receptor-2, urine KIM-1, EGF, monocyte chemoattractant protein-1, and urine alpha-1 microglobulin are each independently associated with CKD progression in children. In this study, we used bootstrapped survival trees to identify a combination of biomarkers to predict CKD progression in children.MethodsThe Chronic Kidney Disease in Children (CKiD) Cohort Study prospectively enrolled children aged 6 months to 16 years with an eGFR of 30-90 ml/min per 1.73 m2. We measured biomarkers in stored plasma and urine collected 5 months after study enrollment. The primary outcome of CKD progression was a composite of 50% eGFR decline or kidney failure. We constructed a regression tree-based model for predicting the time to the composite event, using a panel of clinically relevant biomarkers with empirically derived thresholds, in addition to conventional risk factors.ResultsOf the 599 children included, the median age was 12 years (interquartile range [IQR], 8-15), 371 (62%) were male, baseline urine protein-creatinine ratio was 0.33 (IQR, 0.12-0.95) mg/mg, and baseline eGFR was 53 (IQR, 40-66) ml/min per 1.73 m2. Overall, 205 children (34%) reached the primary outcome of CKD progression. A single regression tree-based model using the most informative predictors with data-driven biomarker thresholds suggested a final set of four prognosis groups. In the final model, urine albumin/creatinine was the variable with the highest importance and along with urine EGF/creatinine identified the highest risk group of 24 children, 100% of whom developed CKD progression at a median time of 1.3 years (95% confidence interval [CI], 1.0 to 1.7). When the regression tree-derived risk group classifications were added to prediction models including the clinical risk factors, the C-statistic increased from 0.76 (95% CI, 0.71 to 0.80) to 0.85 (95% CI, 0.81 to 0.88).ConclusionsUsing regression tree-based methods, we identified a biomarker panel of urine albumin/creatinine, urine EGF/creatinine, plasma KIM-1, and eGFR, which significantly improved discrimination for CKD progression.
引用
收藏
页数:11
相关论文
共 23 条
  • [11] Breiman L., Random forests, Machine learning, 45, 1, pp. 5-32, (2001)
  • [12] Calhoun P., Su X.G., Nunn M., Fan J.J., Constructing Multivariate Survival Trees: The MST Package for R, J Stat Softw, 83, 12, pp. 1-21, (2018)
  • [13] Leblanc M., Crowley J., Survival Trees by Goodness of Split, J Am Stat Assoc, 88, 422, pp. 457-467, (1993)
  • [14] Uno H., Cai T., Pencina M.J., D'Agostino R.B., Wei L.J., On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data, Statistics in medicine, 30, 10, pp. 1105-1117, (2011)
  • [15] Uno H., Tian L., Cai T., Kohane I.S., Wei L.J., A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data, Statistics in medicine, 32, 14, pp. 2430-2442, (2013)
  • [16] Tangri N., Stevens L.A., Griffith J., Et al., A predictive model for progression of chronic kidney disease to kidney failure, JAMA: the journal of the American Medical Association, 305, 15, pp. 1553-1559, (2011)
  • [17] Winnicki E., McCulloch C.E., Mitsnefes M.M., Furth S.L., Warady B.A., Ku E., Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease, JAMA pediatrics, 172, 2, pp. 174-180, (2018)
  • [18] Austin P.C., Steyerberg E.W., The Integrated Calibration Index (ICI) and related metrics for quantifying the calibration of logistic regression models, Statistics in medicine, 38, 21, pp. 4051-4065, (2019)
  • [19] Van Calster B., Nieboer D., Vergouwe Y., De Cock B., Pencina M.J., Steyerberg E.W., A calibration hierarchy for risk models was defined: from utopia to empirical data, Journal of clinical epidemiology, 74, pp. 167-176, (2016)
  • [20] Avner E.D., Harmon W.E., Niaudet P., Yoshikawa N., Pediatric nephrology, (2009)